SecSonar.com

CollPlant Biotechnologies Ltd. (CLGN)

CollPlant Biotechnologies Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

CollPlant Biotechnologies Ltd. (CLGN) is a Biotechnology company based in IL with a market capitalization of $5M. Revenue grew 360.4% year-over-year and free cash flow was negative at -$9.4M. This page tracks CLGN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 57 employees · IPO Jan 31, 2018

Valuation

Valuation & price

$0.42 · as of May 26, 2026 · -86.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.83

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.14$1.73$0.32Jul 25Dec 25Jul 26Jul 7, 25$1.35Jul 9, 25$1.39Jul 11, 25$1.44Jul 15, 25$1.73Jul 17, 25$1.82Jul 21, 25$2.24Jul 23, 25$2.45Jul 25, 25$2.31Jul 29, 25$2.43Jul 31, 25$2.42Aug 4, 25$2.25Aug 6, 25$2.77Aug 11, 25$2.98Aug 13, 25$2.72Aug 15, 25$2.55Aug 19, 25$2.47Aug 21, 25$2.40Aug 25, 25$2.63Aug 27, 25$2.91Aug 29, 25$2.62Sep 3, 25$2.60Sep 5, 25$2.72Sep 9, 25$2.66Sep 11, 25$2.71Sep 16, 25$2.58Sep 18, 25$2.64Sep 22, 25$2.49Sep 24, 25$2.54Sep 26, 25$3.14Sep 30, 25$2.69Oct 2, 25$2.46Oct 6, 25$2.38Oct 8, 25$2.29Oct 10, 25$2.20Oct 14, 25$2.32Oct 16, 25$2.34Oct 21, 25$2.37Oct 23, 25$2.28Oct 27, 25$2.34Oct 29, 25$2.20Oct 31, 25$2.16Nov 4, 25$2.22Nov 6, 25$2.18Nov 10, 25$1.96Nov 12, 25$1.89Nov 14, 25$1.98Nov 18, 25$2.15Nov 20, 25$2.14Nov 25, 25$2.24Nov 28, 25$2.19Dec 2, 25$2.14Dec 4, 25$2.10Dec 8, 25$2.04Dec 10, 25$1.81Dec 12, 25$1.81Dec 16, 25$1.53Dec 18, 25$1.38Dec 22, 25$1.56Dec 24, 25$1.47Dec 29, 25$1.44Jan 2, 26$1.48Jan 6, 26$1.45Jan 8, 26$1.44Jan 12, 26$1.51Jan 14, 26$1.67Jan 16, 26$1.50Jan 21, 26$1.41Jan 23, 26$1.90Jan 27, 26$1.95Jan 29, 26$1.91Feb 2, 26$1.84Feb 4, 26$1.61Feb 9, 26$0.64Feb 11, 26$0.67Feb 13, 26$0.72Feb 18, 26$0.62Feb 20, 26$0.62Feb 24, 26$0.62Feb 26, 26$0.57Mar 2, 26$0.55Mar 4, 26$0.63Mar 6, 26$0.61Mar 10, 26$0.62Mar 12, 26$0.59Mar 17, 26$0.60Mar 19, 26$0.61Mar 23, 26$0.61Mar 25, 26$0.75Mar 27, 26$0.62Mar 31, 26$0.54Apr 2, 26$0.53Apr 7, 26$0.36Apr 9, 26$0.38Apr 13, 26$0.32Apr 15, 26$0.32Apr 17, 26$0.36Apr 22, 26$0.39Apr 24, 26$0.42Apr 28, 26$0.39Apr 30, 26$0.38May 4, 26$0.42May 6, 26$0.41May 8, 26$0.40May 12, 26$0.41May 14, 26$0.42May 18, 26$0.43May 20, 26$0.45May 22, 26$0.43May 28, 26$0.41Jun 1, 26$0.40Jun 3, 26$0.40Jun 5, 26$0.37Jun 9, 26$0.37Jun 11, 26$0.33Jun 15, 26$0.33Jun 17, 26$0.34Jun 22, 26$0.34Jun 24, 26$0.34Jun 26, 26$0.33Jul 2, 26$0.34
$0.2952-week range$3.15
Loading valuation history…

Fundamentals

Key fundamentals

$5M

Market cap

360.4%

Revenue growth (YoY)

26.3%

Gross margin

-$9.4M

Free cash flow (USD)

-$3.1M

Net debt

Net cash position

6.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$75.9KFY 2017$479.9KFY 2018$4.8MFY 2019$2.3MFY 2020$6.1MFY 2021$15.6MFY 2022$299.0KFY 2023$11.0MFY 2024$515.0KFY 2025$2.4M
$75.9K$2.4M

Free cash flow by year

2016 → 2025

FY 2016$-5.2MFY 2017$-5.1MFY 2018$-2.0MFY 2019$-7.2MFY 2020$-4.9MFY 2021$1.1MFY 2022$-15.0MFY 2023$-3.7MFY 2024$-14.6MFY 2025$-9.4M
-$5.2M-$9.4M

Gross margin by year

2021 → 2025

FY 202187.2%FY 2022-393.6%FY 202371.8%FY 2024-417.1%FY 202526.3%
87.2%26.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 29, 2026 (EPS $-0.23)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingSecurities Purchase AgreementJul 1, 2026Filing
  • Annual reportAnnual Report FiledMay 29, 2026Filing
  • 6-K filingDevelopment Agreement TerminationApr 13, 2026Filing

Questions

Frequently asked questions

What is CollPlant Biotechnologies Ltd.'s market cap?

CollPlant Biotechnologies Ltd. (CLGN) has a market capitalization of $5M.

What is CLGN's P/E ratio?

A meaningful P/E ratio is not available for CLGN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CLGN's price-to-book (P/B) ratio?

CLGN trades at 0.83 times book value per share.

When did CollPlant Biotechnologies Ltd. last report earnings?

CLGN last reported earnings on May 29, 2026; the next date is not yet scheduled.

Are insiders buying CLGN stock?

SEC Form 4 filings show no open-market insider buys at CollPlant Biotechnologies Ltd. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

PULM

Pulmatrix, Inc.

$5M

BCAB

BioAtla, Inc.

$5M

ADXN

Addex Therapeutics Ltd

$5M

APM

Aptorum Group Limited

$5.3M

BRTX

BioRestorative Therapies, Inc.

$4.6M

BCDA

BioCardia, Inc.

$5.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.